Search details
1.
Senescence-associated reprogramming promotes cancer stemness.
Nature
; 553(7686): 96-100, 2018 01 04.
Article
in English
| MEDLINE | ID: mdl-29258294
2.
Fingolimod after a first unilateral episode of acute optic neuritis (MOVING) - preliminary results from a randomized, rater-blind, active-controlled, phase 2 trial.
BMC Neurol
; 20(1): 75, 2020 Mar 03.
Article
in English
| MEDLINE | ID: mdl-32126977
3.
Synthetic lethal metabolic targeting of cellular senescence in cancer therapy.
Nature
; 501(7467): 421-5, 2013 Sep 19.
Article
in English
| MEDLINE | ID: mdl-23945590
4.
Opposing roles of NF-κB in anti-cancer treatment outcome unveiled by cross-species investigations.
Genes Dev
; 25(20): 2137-46, 2011 Oct 15.
Article
in English
| MEDLINE | ID: mdl-21979374
5.
A standardised frankincense extract reduces disease activity in relapsing-remitting multiple sclerosis (the SABA phase IIa trial).
J Neurol Neurosurg Psychiatry
; 89(4): 330-338, 2018 04.
Article
in English
| MEDLINE | ID: mdl-29248894
6.
Gadopentetate but not gadobutrol accumulates in the dentate nucleus of multiple sclerosis patients.
Mult Scler
; 23(7): 963-972, 2017 Jun.
Article
in English
| MEDLINE | ID: mdl-27679460
7.
Diagnostic criteria for Susac syndrome.
J Neurol Neurosurg Psychiatry
; 87(12): 1287-1295, 2016 Dec.
Article
in English
| MEDLINE | ID: mdl-28103199
8.
Low 25-hydroxyvitamin D, but not the bioavailable fraction of 25-hydroxyvitamin D, is a risk factor for multiple sclerosis.
Eur J Neurol
; 23(1): 62-7, 2016 Jan.
Article
in English
| MEDLINE | ID: mdl-26220765
9.
RETINAL LESION EVOLUTION IN SUSAC SYNDROME.
Retina
; 36(2): 366-74, 2016 Feb.
Article
in English
| MEDLINE | ID: mdl-26200513
10.
Optic radiation damage in multiple sclerosis is associated with visual dysfunction and retinal thinning--an ultrahigh-field MR pilot study.
Eur Radiol
; 25(1): 122-31, 2015 Jan.
Article
in English
| MEDLINE | ID: mdl-25129119
11.
Clinical, paraclinical and serological findings in Susac syndrome: an international multicenter study.
J Neuroinflammation
; 11: 46, 2014 Mar 08.
Article
in English
| MEDLINE | ID: mdl-24606999
12.
Identical lesion morphology in primary progressive and relapsing-remitting MS--an ultrahigh field MRI study.
Mult Scler
; 20(14): 1866-71, 2014 Dec.
Article
in English
| MEDLINE | ID: mdl-24781284
13.
Comprehensive analysis of microRNA profiles in multiple sclerosis including next-generation sequencing.
Mult Scler
; 20(3): 295-303, 2014 Mar.
Article
in English
| MEDLINE | ID: mdl-23836875
14.
Effects of deep repetitive transcranial magnetic stimulation on brain-derived neurotrophic factor serum concentration in healthy volunteers.
Neuropsychobiology
; 69(2): 112-9, 2014.
Article
in English
| MEDLINE | ID: mdl-24643119
15.
Relations of low contrast visual acuity, quality of life and multiple sclerosis functional composite: a cross-sectional analysis.
BMC Neurol
; 14: 31, 2014 Feb 20.
Article
in English
| MEDLINE | ID: mdl-24555757
16.
Susac syndrome treated with subcutaneous immunoglobulin.
Eur Neurol
; 71(1-2): 89-92, 2014.
Article
in English
| MEDLINE | ID: mdl-24335148
17.
Clinical Characterization and Ancillary Tests in Susac Syndrome: A Systematic Review.
Neurol Neuroimmunol Neuroinflamm
; 11(3): e200209, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38364193
18.
Passenger Gene Coamplifications Create Collateral Therapeutic Vulnerabilities in Cancer.
Cancer Discov
; 14(3): 492-507, 2024 Mar 01.
Article
in English
| MEDLINE | ID: mdl-38197697
19.
Periventricular venous density in multiple sclerosis is inversely associated with T2 lesion count: a 7 Tesla MRI study.
Mult Scler
; 19(3): 316-25, 2013 Mar.
Article
in English
| MEDLINE | ID: mdl-22736752
20.
Optic neuritis interferes with optical coherence tomography and magnetic resonance imaging correlations.
Mult Scler
; 19(4): 443-50, 2013 Apr.
Article
in English
| MEDLINE | ID: mdl-22936335